**Core Concept**
Congenital glaucoma is a condition characterized by increased intraocular pressure (IOP) in infants and young children due to abnormalities in the trabecular meshwork or other parts of the anterior segment. The goal of treatment is to reduce IOP and prevent vision loss.

**Why the Correct Answer is Right**
The primary treatment for congenital glaucoma involves the use of medications to reduce IOP. **Beta-blockers**, such as timolol, and **carbonic anhydrase inhibitors**, like acetazolamide, are commonly used to decrease aqueous humor production. In some cases, **miotics** like pilocarpine may be used to increase the outflow of aqueous humor. Surgery, including trabeculotomy and trabeculectomy, may also be necessary to create a new drainage pathway for the aqueous humor.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a treatment for congenital glaucoma. While it is true that some glaucoma treatments involve laser procedures, this option is too vague and does not accurately reflect the typical treatment approach for congenital glaucoma.
**Option B:** This option is incorrect because it mentions a treatment for acute angle-closure glaucoma, not congenital glaucoma. Hyperosmotic agents like mannitol are used to quickly reduce IOP in acute angle-closure glaucoma, but they are not a primary treatment for congenital glaucoma.
**Option C:** This option is incorrect because it mentions a treatment for open-angle glaucoma, not congenital glaucoma. Laser trabeculoplasty is a common treatment for open-angle glaucoma, but it is not typically used for congenital glaucoma.

**Clinical Pearl / High-Yield Fact**
It is essential to diagnose and treat congenital glaucoma promptly to prevent vision loss and amblyopia. A delay in treatment can lead to permanent vision impairment.

**Correct Answer:** B. Acetazolamide, a carbonic anhydrase inhibitor, is used to reduce IOP in congenital glaucoma.